Skip to search.
 FTSE 100 Up 0.20%

More On MKGAF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Merck KGaA (MKGAF)

-Other OTC
106.51 Up 0.65(0.61%) 25 Jul 18:45
|Pre-Market : NaN
Prev Close:105.87
Open:106.51
Bid:N/A
Ask:N/A
1y Target Est:28.00
Beta:0.753634
Next Earnings Date:N/A
Day's Range:106.51 - 106.51
52wk Range:83.07 - 106.96
Volume:8
Avg Vol (3m):1,129
Market Cap:46.31b
P/E (ttm):29.59
EPS (ttm):3.60
Div & Yield:1.20 (1.14%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.10
Ex-Dividend Date:02-May-16

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck Kommanditgesellschaft auf Aktien discovers, develops, manufactures, and markets pharmaceutical and chemical products worldwide. It operates through three segments: Healthcare, Life Science, and Performance Materials. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback